Portfolio company
Forcefield Therapeutics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops protein-based therapeutics designed to protect heart function and prevent cell death in patients following a heart attack.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cardior
This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.
Serca Pharmaceuticals
This company develops cardioprotective drugs to treat patients suffering from myocardial infarction and heart failure by modulating the SERCA2 calcium pump.
Cardior Pharmaceuticals
This biopharmaceutical company develops RNA-based therapeutics to prevent and repair heart disease for patients with conditions such as heart failure and myocardial infarction.
NanoPhoria
This company develops an inhalable nano-drug delivery platform and therapeutics for patients with heart failure and other cardiovascular diseases.
Brano Therapeutics
This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.
CellAegis Devices
This company develops automated remote ischaemic conditioning devices for patients experiencing heart attacks or undergoing surgical procedures to protect organs from tissue damage.
Epoqe Pharma
The company develops peptide-based heart rescue therapies to treat acute myocardial infarction for patients with cardiovascular diseases.
ClotProtect
This therapeutics company develops a small molecule drug to treat acute bleeding and improve survival for patients suffering from trauma or undergoing surgery.